Remove tag endo
article thumbnail

PharmaShots Weekly Snapshots (June 19 – 23, 2023)

PharmaShots

Gilead Receives EMA’s CHMP Positive Opinion of Trodelvy (sacituzumab govitecan) for Pre-Treated HR+/HER2- Metastatic Breast Cancer Date: June 23, 2023 | Tags: Gilead, Trodelvy, sacituzumab govitecan, HR+/HER2- Metastatic Breast Cancer, Regulatory, EMA, CHMP, Positive Opinion Sarepta Therapeutics’ Elevidys Receives the US FDA’s Accelerated (..)

FDA 40
article thumbnail

A history of Johnson & Johnson

pharmaphorum

During the 1990s, Ethicon’s Endo-Surgery pioneered minimally invasive surgery, which uses very small incisions and helps patients recover faster than with traditional surgery. For all the latest pharma news on Johnson & Johnson, follow pharmaphorum’s J&J and Janssen tags.

Vaccines 125